Pear Therapeutics, Inc. announced resignation of Corey McCann, M.D., Ph.D. as President. Christopher D.T. Guiffre, J.D., M.B.A., the Company's Chief Operating Officer, and Chief Financial Officer will serve as the Company's principal executive officer following the departure of Dr. McCann. Dr. McCann will continue to serve as a member of the Board.